Medicenna Therapeutics Depreciation & Amortization Growth & History (MDNAF)

Medicenna Therapeutics's depreciation and amortization was $72,000 for fiscal 2026.

View full Medicenna Therapeutics company overview

Medicenna Therapeutics annual depreciation and amortization history

Medicenna Therapeutics annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20262026-03-31$72,000$19,000+35.85%
20252025-03-31$53,000$49,000+1225.00%
20242024-03-31$4,000−$1,000−20.00%
20232023-03-31$5,000−$32,000−86.49%
20222022-03-31$37,000−$3,000−7.50%
20212021-03-31$40,000$32,000+400.00%
20202020-03-31$8,000

Medicenna Therapeutics depreciation and amortization trends

Over the last five fiscal years, Medicenna Therapeutics's depreciation and amortization increased from $40,000 to $72,000, a change of $32,000. The latest reported quarter, Q1 2027, shows $17,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Medicenna Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about MDNAF yet. Start the conversation.

Write the first post